MedTwenty

Market Intelligence

Where healthcare money is moving

Segment sizing, growth, year-to-date investment and the companies that define each market. Structure first, coverage widens as verified events accumulate.

Healthcare AI

MedTwenty 88

Clinical and operational AI across documentation, imaging, triage and pathology.

Market size£2.1bn (UK, 2026)
Growth29% CAGR
Investment YTD£0.9bn

Diagnostics

MedTwenty 83

Laboratory, molecular and imaging diagnostics across NHS and independent providers, plus the genomics segment.

Market size£8.4bn (UK, 2026)
Growth11% CAGR
Investment YTD£1.4bn

Pharmaceuticals

MedTwenty 81

Branded and generic pharmaceutical supply, pricing and NICE appraisal outcomes.

Market size£32.1bn (UK, 2026)
Growth5% CAGR
Investment YTD£3.1bn

Life Sciences

MedTwenty 79

Research infrastructure, laboratory real estate and contract research capacity.

Market size£19.6bn (UK, 2026)
Growth8% CAGR
Investment YTD£2.8bn

Digital Health

MedTwenty 76

Virtual care, remote monitoring, digital therapeutics and patient-facing platforms.

Market size£4.6bn (UK, 2026)
Growth14% CAGR
Investment YTD£1.1bn

Medical Devices

MedTwenty 74

Device manufacture, distribution and NHS procurement across therapeutic areas.

Market size£11.2bn (UK, 2026)
Growth6% CAGR
Investment YTD£4.2bn

NHS trusts and independent hospital groups, elective activity and capacity.

Market size£164bn (UK, 2026)
Growth4% CAGR
Investment YTD£1.9bn

Disease areas tracked

OncologyCardiovascularNeurologyDiabetesMusculoskeletalBreast CancerLung CancerStrokeSickle Cell Disease